Analysis Metabolite Name Measured Value Units Construct
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+CL)-1560Peak areaControl lentivirus
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+CL)-20191Peak areaNoxa knockdown
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+CL)-1448538Peak areaControl lentivirus
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+CL)-Peak areaControl lentivirus
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+CL)-Peak areaNoxa knockdown
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+HCOO)-1339Peak areaNoxa knockdown
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+HCOO)-1646Peak areaControl lentivirus
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+HCOO)-20134Peak areaNoxa knockdown
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+HCOO)-1099613Peak areaControl lentivirus
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+HCOO)-Peak areaControl lentivirus
Reversed phase NEGATIVE ION MODECORTISONE (CAS# 53-06-5); (M+HCOO)-Peak areaNoxa knockdown
Reversed phase POSITIVE ION MODECORTISONE (CAS# 53-06-5); (M+H)+125537Peak areaControl lentivirus
Reversed phase POSITIVE ION MODECORTISONE (CAS# 53-06-5); (M+H)+Peak areaControl lentivirus
Reversed phase POSITIVE ION MODECORTISONE (CAS# 53-06-5); (M+H)+Peak areaNoxa knockdown
Reversed phase POSITIVE ION MODECORTISONE (CAS# 53-06-5); (M+NA)+25917Peak areaNoxa knockdown
Reversed phase POSITIVE ION MODECORTISONE (CAS# 53-06-5); (M+NA)+1332489Peak areaControl lentivirus
Reversed phase POSITIVE ION MODECORTISONE (CAS# 53-06-5); (M+NA)+Peak areaControl lentivirus
Reversed phase POSITIVE ION MODECORTISONE (CAS# 53-06-5); (M+NA)+Peak areaNoxa knockdown

Return to search page
  logo